Spontaneous bacterial peritonitis (SBP): Clinical, laboratory, and prognostic features: A single-center experience

European Journal of Internal Medicine

Volumn 13, Issue 3, 2002, Pages 194-198

  Thanopoulou, Anastasia C ^a   Koskinas, John S ^a   Hadziyannis, Stephanos J ^a  

^a HIPPOKRATION HOSPITAL   (Greece)

Author keywords

Relapse; Renal impairment; Spontaneous bacterial peritonitis (SBP); Survival

Indexed keywords

BILIRUBIN; CEFOTAXIME; CIPROFLOXACIN; DIURETIC AGENT;

ADULT; ARTICLE; ASCITES FLUID; BACTERIAL PERITONITIS; BRAIN DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; FEMALE; GREECE; HEPATORENAL SYNDROME; HUMAN; KIDNEY FUNCTION; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; POLYMORPHONUCLEAR CELL; PROGNOSIS; RECURRENCE RISK;

EID: 0036098638     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0953-6205(02)00027-4     Document Type: Article

References (26)

1. Peritonitis: Update on pathophysiology, clinical manifestations and management. State of the art clinical article
2. Spontaneous bacterial peritonitis. Detection, treatment and prophylaxis in patients with liver cirrhosis
3. Ascites and spontaneous bacterial peritonitis
4. Subspecialty clinics: Gastroenterology. Spontaneous bacterial peritonitis: An update
5. Spontaneous bacterial peritonitis: Let's not make the same mistakes
6. Spontaneous bacterial peritonitis: Pathogenesis, diagnosis and management
7. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis
8. Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: Relationship with the development of renal impairment and mortality
9. Renal impairment after spontaneous bacterial peritonitis in cirrhosis: Incidence, clinical course, predictive factors and prognosis
10. Spontaneous bacterial peritonitis in cirrhosis: Clinical and laboratory features, survival and prognostic indicators
11. Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: Results of a double-blind, placebo-controlled trial
12. Spontaneous ascitic infection in different cirrhotic groups: Prevalence, risk factors and the efficacy of cefotaxime therapy
13. Prevalence and prognostic significance of bacterascites in cirrhosis with ascites
14. Short-term prognosis of cirrhotics with spontaneous bacterial peritonitis: Multivariate study
15. Spontaneous bacterial peritonitis in liver failure
16. Ceftriaxone in the treatment of spontaneous bacterial peritonitis: Ascitic fluid polymorphonuclear count response and short-term prognosis
17. Changes in nature and antibiotic resistance of bacteria causing peritonitis in cirrhotic patients over a 20 year period
18. Prevalence of peritonitis and the ascitic fluid protein concentration among chronic liver disease patients
19. Justification of routine puncture of ascites in cirrhotic patients admitted to emergency hospital units
20. Risk factors for spontaneous bacterial peritonitis in cirrhotic patients with ascites
21. Spontaneous bacterial peritonitis: An update on evaluation, management and prevention
22. Intravenous albumin for spontaneous bacterial peritonitis in patients with cirrhosis
23. Management of adult patients with ascites caused by cirrhosis
24. Hepatorenal syndrome and ascites - Questions and answers
25. Spontaneous bacterial peritonitis in cirrhosis: Predictive factors of infection resolution and survival in patients treated with cefotaxime
26. Recurrence of spontaneous bacterial peritonitis in cirrhosis: Frequency and predictive factors